CYP 3.64% 28.5¢ cynata therapeutics limited

Ann: Cynata GvHD Trial Meets all Safety & Efficacy Endpoints, page-10

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 35,472 Posts.
    lightbulb Created with Sketch. 2863
    The last 28 day update was also of course good.
    about 11c range but open higher and closed down...then drifted to down after that.

    So we're waiting on CLI now...

    but what's happened to Asthma?

    March 2017
    “We are optimistic that this accelerated program will pave the way forward for a clinical trial in asthma patients in the near future”, added Dr Kelly.

    18 months ago, all pre-clinical was finished by DEC 2017...with great results, much better than bone marrow.

    ??? NO updates

    huge market - 25x GvHD

    Cynata has just not put the foot down enough.
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.